17 analysts have shared their evaluations of Confluent CFLT during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 8 | 4 | 1 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 3 | 8 | 3 | 1 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $25.76, a high estimate of $34.00, and a low estimate of $21.00. A 32.42% drop is evident in the current average compared to the previous average price target of $38.12.
Exploring Analyst Ratings: An In-Depth Overview
A clear picture of Confluent's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Yun Kim | Loop Capital | Announces | Hold | $23.00 | - |
Mike Cikos | Needham | Raises | Buy | $30.00 | $23.00 |
Peter Weed | Bernstein | Announces | Outperform | $34.00 | - |
Connor Murphy | Capital One | Announces | Overweight | $27.00 | - |
Matthew Hedberg | RBC Capital | Announces | Outperform | $22.00 | - |
Patrick Walravens | JMP Securities | Lowers | Market Outperform | $25.00 | $41.00 |
Joel Fishbein | Truist Securities | Lowers | Buy | $27.00 | $42.00 |
Kash Rangan | Goldman Sachs | Lowers | Neutral | $24.00 | $35.00 |
Kingsley Crane | Canaccord Genuity | Announces | Hold | $26.00 | - |
Allan Verkhovski | Wolfe Research | Announces | Outperform | $21.00 | - |
Howard Ma | Guggenheim | Announces | Buy | $23.00 | - |
Rob Owens | Piper Sandler | Lowers | Overweight | $30.00 | $40.00 |
Sanjit Singh | Morgan Stanley | Lowers | Overweight | $27.00 | $40.00 |
Kingsley Crane | Canaccord Genuity | Announces | Hold | $26.00 | - |
Raimo Lenschow | Barclays | Lowers | Overweight | $26.00 | $39.00 |
Brad Sills | B of A Securities | Announces | Underperform | $24.00 | - |
Mike Cikos | Needham | Lowers | Buy | $23.00 | $45.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Confluent. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Confluent compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Confluent's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Confluent's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Confluent analyst ratings.
Get to Know Confluent Better
Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. It provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.
A Deep Dive into Confluent's Financials
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Confluent's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2023, the company achieved a revenue growth rate of approximately 31.93%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Confluent's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -46.29%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -11.95%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Confluent's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -3.95%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Confluent's debt-to-equity ratio stands notably higher than the industry average, reaching 1.41. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: Simplified
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.